Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3004269	du-iglck	— (—)	486	1547	100.00%	Distribution not available
3004269	du-iglck	mg/24h (mg/24h)	5	5	0.00%	Distribution not available	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

115

111.36

224.40

3.3

1.1

—

Amyloidosis

71.64

36.29

4.4

4.3

—

Amyloidosis, other/unspecified

80.59

34.20

4.6

5.0

—

Disorders of calcium metabolism

8.95

25.07

4.5

3.4

—

Hypercalcemia

11.92

15.07

3.7

—

Heart failure and bmi 25plus

162

2.63

10.57

2.5

3.3

—

Organ-limited amyloidosis

+∞

10.52

2.5

0.0

—

Spondylopathies in diseases classified elsewhere

19.35

10.32

4.0

1.9

—

Chronic nephritic syndrome

14.68

10.00

3.0

5.5

—

Depression medications

7.97

9.95

3.0

1.6

—

Osteonecrosis due to drugs

20.53

9.85

3.6

2.0

—

Hyperkalaemia

6.71

8.35

3.1

3.3

—

Secondary hypertension

6.73

7.97

4.4

3.4

—

Atrial fibrillation and flutter with reimbursement

3.23

7.82

2.1

3.2

—

Secondary systemic amyloidosis

+∞

7.37

2.9

0.0

—

Hypertensive Renal Disease

8.40

7.32

2.7

3.7

—

Hypothyroidism, levothyroxine purchases

8.01

7.07

2.9

1.6

—

Hypothyroidism and >3 levothyroxin purchases

8.01

7.07

2.9

1.6

—

Hypothyroidism (congenital or acquired)

8.01

7.07

2.9

1.6

—

Osteonecrosis

6.04

7.07

3.2

2.9

—

Viral pneumonia (known virus, not influenza)

13.89

6.90

4.2

1.9

—

Paroxysmal tachycardia

3.27

6.58

1.6

3.3

—

Rare circulating lymphoid malignancy, including Hilmo

18.12

6.27

3.0

1.2

—

Cardiovascular diseases (excluding rheumatic etc)

2.56

6.24

3.1

3.3

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.64

6.15

2.6

3.4

—

Protozoal diseases

8.40

5.06

3.3

2.8

—

Pneumocystosis

10.10

4.53

3.8

2.6

—

Pain in thoracic spine

2.86

4.48

3.0

3.6

—

Cardiovascular diseases

2.34

4.46

2.9

3.2

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

4.73

4.45

1.9

4.4

—

Viral pneumonia (unknown virus, not influenza)

4.01

4.09

3.4

3.5

—

Other CVD (FINNGEN)

3.19

4.03

4.0

3.3

—

Hypoparathyroidism

6.46

3.98

5.7

2.1

—

Implicit fungal Sepsis

5.59

3.97

4.4

3.0

—

Neurological diseases, wide definition

3.28

3.90

2.8

4.3

—

Antihypertensive medication - note that there are other indications

2.14

3.90

2.4

4.4

—

Other dialysis

6.04

3.82

3.8

3.7

—

Other/unspecified cytomegaloviral diseases

8.82

3.78

6.0

2.6

—

Cytomegaloviral disease

8.81

3.78

6.0

1.9

—

L01XX Other antineoplastic agents

3.73

3.59

2.4

3.1

—

Cytomegalovirus infection, IBD co-morbidity

7.83

3.56

6.0

2.4

—

Fungal Sepsis

4.79

3.55

4.4

2.7

—

Hypothyroidism, drug reimbursement

5.78

3.49

4.8

1.5

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2.51

3.44

3.0

4.0

—

Menorrhagia

2.21

3.43

2.1

3.2

—

Malignant neoplasm of endocrine gland

5.73

3.34

6.3

1.1

—

Malignant neoplasm of other connective and soft tissue

8.62

3.26

5.3

1.1

—

ILD medications: azathioprine

3.53

3.19

2.2

2.4

—

Disorders of continuity of bone

3.55

2.98

2.9

3.1

—

Diabetes mellitus in pregnancy

0.00

2.89

0.0

4.3

—

Drug-induced osteoporosis with pathological fracture

6.72

2.87

1.2

2.6

—

Malignant neoplasm of mesothelium and soft tissue

6.69

2.87

5.3

1.4

—

Implicit fungal Sepsis

3.34

2.81

4.1

2.8

—

Acute generalized exanthematous pustulosis

4.46

2.79

7.0

3.1

—

Malignant neoplasm of thyroid gland

5.01

2.73

6.9

1.1

—

Malignant neoplasm of thyroid gland, including Hilmo

5.01

2.72

6.9

1.1

—

Immunodeficiency with predominantly antibody defects

6.03

2.70

3.2

3.0

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

6.02

2.70

5.3

1.4

—

Chronic tubulo-interstitial nephritis

6.02

2.70

1.2

3.9

—

Excessive, frequent and irregular menstruation

2.03

2.66

2.4

3.2

—

Diabetic retinopathy, excluding more controls

2.02

2.65

1.9

—

Generalized skin eruption due to drugs and medicaments

4.68

2.60

7.7

2.9

—

Eustachian salpingitis and obstruction

4.67

2.59

2.4

3.1

—

Acute suppurative otitis media

2.46

2.57

3.3

3.6

—

Sicca syndrome [Sjögren]

3.06

2.56

1.3

2.6

—

Myeloid leukaemia

5.48

2.54

3.3

3.1

—

Acute pharyngitis

3.03

2.53

1.8

3.6

—

ILD, hospital admissions 3, with pneumonia sepsis

2.67

2.45

2.0

2.7

—

Other disorders of white blood cells

3.34

2.39

1.7

3.6

—

Heart failure and hypertrophic cardiomyopathy

6.29

2.37

4.4

1.9

—

Varicella [chickenpox]

4.63

2.27

7.5

5.1

—

Other and unspecified disorders of white blood cells

3.90

2.25

1.7

3.4

—

Immunodeficiencies

3.90

2.25

3.7

3.2

—

Acquired haemolytic anaemia

5.58

2.21

3.0

2.4

—

Pruritus

2.50

2.18

1.9

3.1

—

Other specified/unspecified spondylopathies

4.31

2.15

1.3

3.6

—

Infectious mononucleosis

4.29

2.15

2.0

4.4

—

Myocarditis

4.29

2.15

3.2

4.6

—

Varicella [chickenpox]

4.29

2.15

7.5

4.8

—

Primary hyperparathyroidism

2.37

2.12

1.8

2.9

—

ILD, hospital admission 2, with pulmonary infections

2.45

2.10

2.0

2.7

—

Orthopaedic devices associated with adverse incidents

5.03

2.07

1.0

2.3

—

Pneumonia due to other infectious organisms, not elsewhere classified

3.51

2.05

6.6

3.1

—

Small fibre neuropathy

4.02

2.04

2.3

4.1

—

Other diseases of spinal cord

4.02

2.04

3.8

3.3

—

Chorioretinal inflammation

4.56

1.94

1.6

2.6

—

Retained placenta and membranes, without haemorrhage

2.57

1.94

2.5

2.6

—

Chondrocostal junction syndrome [Tietze]

3.76

1.93

1.7

3.6

—

Other specified/unspecified systemic involvement of connective tissue

2.97

1.93

1.1

3.2

—

Diseases of tongue

3.76

1.93

2.5

3.6

—

Fibromyalgia

2.73

1.93

1.4

3.2

—

Pre-eclampsia

2.21

1.84

1.5

2.9

—

Complications predominantly related to the puerperium

2.06

1.80

2.7

2.9

—

Tobacco use

3.05

1.80

1.0

3.9

—

Diseases of the skin and subcutaneous tissue

287

1.36

1.74

2.8

3.2

—

37.40

—

Other disorders of adrenal gland

3.34

1.74

3.8

3.1

—

Hypertrophic cardiomyopathy

2.92

1.72

5.4

3.3

—

Dermatitis due to substances taken internally

2.92

1.72

7.7

3.3

—

Haemolytic anaemias

3.86

1.71

3.0

2.9

—

Acute posthaemorrhagic anaemia

3.86

1.71

4.0

2.3

—

Other puerperal infections

3.85

1.71

1.4

3.1

—

Convalescence

3.16

1.66

4.0

2.7

—

Assault by bodily force

3.00

1.58

1.3

3.6

—

Adrenocortical insufficiency

3.34

1.52

4.2

3.4

—

Other and unspecified injuries of wrist and hand

3.34

1.52

2.2

2.3

—

Multiple delivery

3.34

1.52

4.0

3.5

—

Secondary and unspecified malignant neoplasm of lymph nodes

2.86

1.50

1.5

1.6

—

Mixed connective tissue disease

2.50

1.45

1.0

3.1

—

Infective bursitis

3.13

1.44

2.6

4.4

—

Secondary right heart disease

2.73

1.43

3.0

3.3

—

Benign neoplasm: Skin of trunk

2.73

1.43

6.5

4.0

—

Pre-eclampsia or eclampsia

1.94

1.38

1.5

2.9

—

Other intracranial haemorrhages

2.62

1.37

7.3

2.3

—

Other osteochondropathies

2.61

1.36

3.3

3.1

—

Tubulo-interstitial nephritis, not specified as acute or chronic

2.61

1.36

3.3

3.0

—

Hypopituitarism

2.61

1.36

7.2

3.6

—

Ovarian cyst

1.68

1.32

3.7

3.2

—

Postmenopausal osteoporosis with pathological fracture

2.50

1.30

1.8

2.6

—

Other menopausal disorders

0.40

1.30

5.0

3.2

—

therapeutic use

2.79

1.28

1.0

3.6

—

Non-small cell lung cancer, adenocarcinoma

2.78

1.28

2.2

1.6

—

Symptoms and signs concerning food and fluid intake

2.08

1.27

2.6

2.9

—

Other and unspecified disorders of skin and subcutaneous tissue

2.29

1.26

3.0

3.1

—

Other and unspecified drugs and medicaments

2.05

1.26

5.4

2.9

—

Unspecified jaundice

2.40

1.24

3.8

3.2

—

Disorders of thyroid, IBD co-morbidities

2.25

1.24

3.6

4.4

—

Ménière disease

1.97

1.22

5.1

2.8

—

Other salmonella infections

2.64

1.21

4.0

3.3

—

Contact with nonpowered hand tool

2.64

1.21

1.2

3.6

—

Cramp and spasm

2.64

1.21

3.0

3.2

—

Assault

2.16

1.21

1.3

3.9

—

Dermatitis and eczema

408

1.26

1.20

2.8

3.2

—

37.40

—

Mixed hyperlipidaemia

2.31

1.18

1.0

3.8

—

Excessive vomiting in pregnancy

2.31

1.18

1.8

3.3

—

Bacterial, viral and other infectious agents

2.31

1.18

5.0

4.0

—

Disorders of tooth development and eruption

2.09

1.16

3.1

4.9

—

Disorders resulting from impaired renal tubular function

2.51

1.15

1.2

3.8

—

Panniculitis affecting regions of neck and back

2.50

1.15

2.6

4.2

—

Other diseases of pericardium

2.50

1.15

6.6

3.1

—

Astigmatism

2.50

1.15

2.2

3.8

—

Maternal care for known or suspected fetal abnormality and damage

0.00

1.14

0.0

2.7

—

Melanoma in situ

2.26

1.10

6.1

3.3

—

Twin gestation

2.38

1.09

4.0

2.5

—

Atrophic disorders of skin

1.87

1.07

2.4

2.9

—

Puerperal sepsis

1.92

1.06

3.2

2.2

—

Other abnormal findings of blood chemistry

2.28

1.03

3.0

3.1

—

Other salmonella infections

2.28

1.03

4.0

3.5

—

Multiple gestation

2.27

1.03

4.0

2.8

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

1.96

1.03

5.4

2.7

—

Other complications of surgical and medical care, not elsewhere classified

1.92

1.02

2.4

3.0

—

Cholesteatoma of middle ear

0.00

0.97

0.0

3.1

—

Vascular syndromes of brain in cerebrovascular disorders

0.00

0.96

0.0

2.6

—

Presbyopia

0.00

0.96

0.0

3.5

—

Other and unspecified injuries of lower leg

0.00

0.96

0.0

3.0

—

Dysplasia of cervi uteri

1.71

0.94

2.5

3.0

—

Bacterial, viral and other infectious agents

2.22

0.93

5.0

3.9

—

Other pulmonary heart/vessel disease

2.15

0.91

3.0

3.1

—

Impacted teeth

2.14

0.91

2.8

3.7

—

Vocal cord dysfunction

1.89

0.88

2.4

4.4

—

Sequelae of infectious and parasitic diseases

2.00

0.87

3.5

3.4

—

Allergic urticaria

2.00

0.87

5.3

3.0

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

137

0.61

0.86

4.6

3.0

—

Haemangioma, any site

1.82

0.85

6.4

3.0

—

Migraine without aura

1.82

0.85

1.9

4.3

—

Haemangioma and lymphangioma, any site

1.78

0.84

6.4

3.0

—

Tongue abnormality

1.88

0.81

2.3

3.4

—

Postmenopausal atrophic vaginitis

1.50

0.81

2.1

3.1

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

1.70

0.80

2.0

2.7

—

Inflammatory disorders of breast

0.00

0.79

0.0

2.6

—

Pustulosis palmaris et plantaris

0.00

0.79

0.0

3.2

—

Pustular psoriasis

0.00

0.79

0.0

3.2

—

Poor fetal growth

0.00

0.78

0.0

3.2

—

Pregnancy hypertension

117

1.45

0.78

1.5

3.2

—

Pollen allergy

1.65

0.77

3.1

—

Other aneurysm

1.77

0.76

2.2

2.4

—

Trigeminal neuralgia

0.00

0.76

0.0

3.2

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

0.00

0.76

0.0

2.8

—

Complications of labour and delivery

129

1.34

0.75

3.1

2.8

—

Other female pelvic inflammatory diseases

1.64

0.75

3.7

2.7

—

Disturbances of smell and taste

2.09

0.74

1.2

3.5

—

Early lumbar disc prolapse, operated

2.08

0.74

3.4

4.2

—

Obstructed labour due to maternal pelvic abnormality

1.58

0.71

3.6

2.5

—

Early lumbar disc prolapse operation

1.92

0.70

3.4

3.5

—

Cysts of oral region, not elsewhere classified

1.85

0.68

6.2

3.1

—

Other obstructed labour

1.85

0.68

6.2

3.0

—

Gestational diabetes (for exclusion)

0.53

0.68

1.4

3.8

—

Overexertion and strenuous or repetitive movements

1.67

0.68

2.9

3.2

—

Thyrotoxicosis with diffuse goitre

1.53

0.68

3.4

2.8

—

Pre-eclampsia or poor fetal growth

1.52

0.67

1.5

3.2

—

Other/unspecified reactive arthropathies

1.73

0.64

1.6

3.3

—

Use of biperiden

0.00

0.60

0.0

3.6

—

Crohn's disease of large intestine

0.00

0.60

0.0

3.6

—

Cluster headache, wide,, including avohilmo

0.00

0.60

0.0

3.6

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

0.00

0.60

0.0

2.6

—

Hypertrophic disorders of skin

0.00

0.60

0.0

2.8

—

Use of levodopa decarbox-comt-inhibitor

0.00

0.59

0.0

3.0

—

Carcinoma in situ, bladder

0.00

0.59

0.0

3.1

—

Carcinoma in situ of other and unspecified sites

0.00

0.59

0.0

3.1

—

Benign neoplasm: Skin of ear and external auricular canal

0.00

0.59

0.0

3.1

—

Attention to artificial openings

0.00

0.59

0.0

3.0

—

Other Crohn's disease

0.00

0.58

0.0

3.3

—

Herpesviral [herpes simplex] infections

1.51

0.58

3.5

2.8

—

Gestational [pregnancy-induced] hypertension

1.56

0.58

1.4

3.2

—

Postmenopausal bleeding

1.39

0.57

2.6

3.1

—

Maternal care for other conditions predominantly related to pregnancy

1.48

0.57

2.4

4.2

—

Inflammatory diseases of the central nervous system

1.62

0.55

2.3

3.3

—

Spondylolisthesis/Spondylolysis

100

1.40

0.51

3.8

3.5

—

Rash and other nonspecific skin eruption

1.52

0.48

4.1

2.9

—

Lichen sclerosus et atrophicus

1.52

0.48

2.6

2.7

—

Enlarged lymph nodes

1.45

0.48

3.5

3.0

—

Traumatic subdural haemorrhage

1.45

0.47

5.7

2.8

—

Other disorders of the genitourinary system

1.47

0.47

1.9

2.3

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

1.46

0.46

7.3

3.2

—

Benign neoplasm: Cerebral meninges

1.37

0.44

2.7

2.8

—

Perineal laceration during delivery

1.55

0.42

3.0

3.1

—

Allergic asthma (mode)

1.37

0.41

2.0

3.0

—

Disorders of psychological development

0.00

0.41

0.0

3.8

—

Arterial embolism and thrombosis

1.52

0.41

5.6

2.5

—

Deep bite

1.51

0.41

1.8

3.0

—

Chronic conjunctivitis

0.00

0.41

0.0

2.5

—

Other, unspecified and serous retinal detachments

0.00

0.41

0.0

3.5

—

Anisometropia and aniseikonia

0.00

0.41

0.0

3.0

—

Moderate visual impairment, binocular

0.00

0.41

0.0

1.7

—

Cystic kidney disease

0.00

0.41

0.0

3.7

—

Benign neoplasm of other and unspecified sites

0.00

0.41

0.0

3.4

—

Vertical strabismus

0.00

0.41

0.0

3.4

—

Amenorrhoea

0.00

0.41

0.0

3.6

—

Other specified disorders of kidney and ureter

0.00

0.41

0.0

3.3

—

Other specified and unspecified disorders of eye and adnexa

0.00

0.41

0.0

2.8

—

Other congenital malformations of skin

0.00

0.41

0.0

3.6

—

Contusion of other and unspecified parts of foot

0.00

0.41

0.0

3.3

—

Benign neoplasm: Tongue

0.00

0.40

0.0

2.3

—

Secondary parkinsonism, excluding more controls

0.00

0.40

0.0

3.1

—

Peripheral retinal degeneration

0.00

0.40

0.0

3.9

—

Other secondary coxarthrosis

0.00

0.40

0.0

3.2

—

Cystic kidney disease

0.00

0.40

0.0

3.5

—

Right bundle-branch block

0.00

0.40

0.0

3.1

—

Labour and delivery complicated by umbilical cord complications

0.00

0.40

0.0

3.1

—

Caught, crushed, jammed or pinched in or between objects

0.00

0.40

0.0

4.7

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

0.00

0.40

0.0

1.5

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.40

0.0

3.5

—

Prolapse and hernia of ovary and fallopian tube

0.00

0.40

0.0

2.2

—

Other and unspecified psoriasis

1.47

0.40

1.6

3.3

—

Other coagulation defects

1.47

0.40

2.6

3.1

—

Other specified/unspecified dorsopathies

0.00

0.40

0.0

3.0

—

Status epilepticus

0.00

0.40

0.0

5.3

—

Ulcerative ileocolitis

0.00

0.40

0.0

3.8

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

0.40

0.0

3.2

—

All dysplastic lesions of the cervix uteri

1.32

0.40

2.9

3.1

—

Cervicobrachial syndrome

104

0.67

0.39

6.7

3.9

—

Dissection of aorta

0.00

0.39

0.0

2.5

—

Complications following abortion and ectopic and molar pregnancy

0.00

0.39

0.0

2.9

—

Toxic effect of contact with venomous animals

0.00

0.39

0.0

2.4

—

Separation of retinal layers (serosa)

0.00

0.39

0.0

4.2

—

Atopic conjunctivitis

0.00

0.39

0.0

3.1

—

Cluster headache, strict, including avohilmo

0.00

0.39

0.0

3.2

—

Hypertrophic scar

0.00

0.39

0.0

2.8

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.39

0.0

2.4

—

Other specified/unspecified bacterial intestinal infections

1.39

0.38

1.8

3.2

—

Melanocytic naevi, other sites/unspecified

1.39

0.38

4.4

3.3

—

Superficial injury of hip and thigh

1.39

0.36

4.5

2.7

—

Hypertrophy of breast in women and men

0.64

0.35

4.2

2.9

—

Nonalcoholic fatty liver disease

1.40

0.35

2.7

3.5

—

Scabies

1.40

0.35

2.0

3.3

—

Chronic lower respiratory diseases

391

1.10

0.34

3.0

3.2

—

37.40

—

Preterm labour and delivery

1.34

0.34

3.2

2.5

—

Other and unspecified rosacea

1.33

0.33

1.2

2.8

—

Conductive hearing loss, unspecified

1.30

0.33

4.0

3.0

—

Stenosis and insufficiency of lacrimal passages

1.30

0.33

3.0

2.9

—

Undetermined asthma

1.30

0.33

5.8

2.5

—

Haemorrhage in early pregnancy

1.31

0.32

2.2

3.5

—

Other metabolic disorders

1.32

0.30

7.3

3.1

—

Noninflammatory disorders of female genital tract

1.24

0.30

2.7

3.2

—

Long labour

1.25

0.29

4.4

3.3

—

Benign neoplasm of meninges

1.25

0.29

2.7

2.9

—

Ectopic pregnancy

1.29

0.28

2.4

2.8

—

Salpingitis and oophoritis

1.25

0.25

2.6

2.5

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

139

1.19

0.25

1.5

3.5

—

All dysplastic lesions of the cervix uteri, vagina or vulva

1.17

0.24

2.7

3.4

—

Endometriosis ASRM stages 3,4

0.72

0.24

2.8

2.6

—

Delivery, wide proxy

1.21

0.24

2.8

2.7

—

Decubitus ulcer and pressure area

1.32

0.23

1.2

3.1

—

Acute peritonitis

1.32

0.23

1.4

3.1

—

Maternal care for known or suspected malpresentation of fetus

1.29

0.23

3.8

3.5

—

Injury of unspecified body region

1.25

0.22

1.4

3.0

—

Deforming dorsopathies

144

1.18

0.22

3.6

3.5

—

Benign neoplasm: Short bones of upper limb

0.00

0.21

0.0

2.9

—

Oral lichen planus and hypothyroidism or thyroxine medication

0.00

0.21

0.0

2.6

—

Fistulae involving female genital tract

0.00

0.21

0.0

2.5

—

Other specified/unspecified deforming dorsopathies

0.00

0.21

0.0

4.6

—

Allergic contact dermatitis due to drugs in contact with skin

0.00

0.21

0.0

2.9

—

Pneumoconiosis due to asbestos and other mineral fibres

0.00

0.21

0.0

2.5

—

Erythema intertrigo

0.00

0.21

0.0

4.5

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

0.00

0.21

0.0

3.8

—

Torsion of ovary, ovarian pedicle and fallopian tube

0.00

0.21

0.0

2.8

—

Benign neoplasm: Skin of scalp and neck

0.00

0.21

0.0

2.8

—

Syphilis

0.00

0.21

0.0

3.9

—

Syphilis

0.00

0.21

0.0

3.9

—

Polycystic kidney disease

0.00

0.21

0.0

2.2

—

Small cell lung cancer, helper endpoint

0.00

0.21

0.0

1.7

—

Contusion of toe(s) without damage to nail

0.00

0.21

0.0

2.9

—

0.00

0.21

0.0

4.5

—

Abscess of Bartholin gland

0.00

0.21

0.0

2.5

—

Allergic purpura

0.00

0.21

0.0

2.6

—

Other and unspecified intracranial injuries

0.00

0.21

0.0

1.7

—

Nontoxic diffuse goitre

0.00

0.21

0.0

3.0

—

Exposure to other and unspecified animate mechanical forces

0.00

0.21

0.0

2.9

—

Symptoms and signs involving emotional state

0.00

0.21

0.0

3.1

—

Algoneurodystrophy

0.00

0.21

0.0

2.4

—

Other inflammation of vagina/vulva

0.00

0.21

0.0

2.5

—

Complications of the puerperium, not elsewhere classified

0.00

0.21

0.0

2.4

—

Polyhydramnios

0.00

0.21

0.0

3.1

—

Female infertility, associated with anovulation

0.00

0.21

0.0

4.3

—

Abnormal findings on antenatal screening of mother

0.00

0.21

0.0

4.3

—

KRA_PSY_EATING, excluding more controls

0.00

0.21

0.0

2.5

—

Benign neoplasm of male genital organs

0.00

0.21

0.0

3.0

—

Other and unspecified nail disorders

0.00

0.21

0.0

2.6

—

Graves ophthalmopathy, strict

0.00

0.21

0.0

2.8

—

Procedures for purposes other than remedying health state

0.00

0.21

0.0

2.6

—

Other and unspecified degenerative diseases of nervous system

0.00

0.21

0.0

2.7

—

Other and unspecified epidermal thickening

0.00

0.21

0.0

2.7

—

Other lesions of median nerve

0.00

0.21

0.0

3.2

—

LSIL lesion of the vulva

0.00

0.21

0.0

3.4

—

Other facial nerve disorders

0.00

0.21

0.0

2.8

—

Erosion and ectropion of cervix uteri

0.00

0.21

0.0

2.6

—

Embolic stroke with flimmer

0.00

0.21

0.0

2.8

—

Problems related to social environment

0.00

0.21

0.0

2.3

—

Hyperhidrosis

0.00

0.21

0.0

1.8

—

Golimumab

0.00

0.21

0.0

4.0

—

Hidradenitis suppurativa

0.00

0.21

0.0

3.1

—

Cluster headache, strict

0.00

0.21

0.0

5.2

—

Anankastic personality disorder

0.00

0.21

0.0

4.5

—

Congenital ovarian cysts

0.00

0.21

0.0

3.4

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

0.00

0.21

0.0

1.1

—

Other obstetric trauma

0.00

0.21

0.0

2.9

—

Speech and linguistic disorders

0.00

0.21

0.0

3.1

—

Enthesopathies of lower limb, excluding foot

102

0.78

0.21

2.6

3.8

—

Speech and linguistic disorders, excluding more controls

0.00

0.21

0.0

4.2

—

Migraine without aura and triptan purchases

1.16

0.21

1.6

3.4

—

Vascular dementia (mixed)

0.00

0.21

0.0

1.8

—

Autonomic disorders

0.00

0.21

0.0

2.9

—

Graves ophthalmopathy

0.00

0.21

0.0

3.4

—

Other articular cartilage disorders

0.00

0.21

0.0

3.5

—

Benign neoplasm: Anus and anal canal

0.00

0.21

0.0

3.8

—

Disorders of eyelid in diseases classified elsewhere

0.00

0.21

0.0

3.9

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

0.00

0.21

0.0

2.9

—

Diffuse brain injury

0.00

0.21

0.0

3.7

—

Cluster headache, wide

0.00

0.21

0.0

5.0

—

Malignant neoplasm of ovary, including Hilmo

0.00

0.21

0.0

1.3

—

Eating disorder

0.00

0.21

0.0

2.5

—

Alzheimer’s disease (Late onset), excluding more controls

0.78

0.20

2.9

3.3

—

Other retinal artery occlusion

0.00

0.20

0.0

3.1

—

Use of rasagiline

0.00

0.20

0.0

3.1

—

Secondary parkinsonism

0.00

0.20

0.0

3.2

—

Short Achilles tendon (acquired)

0.00

0.20

0.0

2.7

—

Congenital iodine-deficiency syndrome/hypothyroidism

0.00

0.20

0.0

2.5

—

Maternal care for known or suspected disproportion

0.00

0.20

0.0

2.7

—

Open bite

0.00

0.20

0.0

3.5

—

HSIL lesion of the cervix uteri, vagina or vulva

1.20

0.19

1.5

3.3

—

Obstructed labour due to malposition and malpresentation of fetus

1.14

0.19

6.8

3.2

—

Vestibular neuronitis

1.13

0.18

6.2

3.0

—

Adenomyosis (Endometriosis of uterus)

1.13

0.18

1.8

2.8

—

Allergic contact dermatitis

1.21

0.18

2.7

3.2

—

1.19

0.18

5.7

3.1

—

Postpartum hemorraghe, all women as controls

1.17

0.17

3.9

3.6

—

Spontaneous abortion

112

1.14

0.17

2.1

3.2

—

Rheumatism, unspecified

1.14

0.16

1.4

3.1

—

Asthma, including avohilmo

412

1.05

0.13

2.8

3.2

—

37.40

—

Single spontaneous delivery

1.12

0.12

2.8

2.9

—

Female genital prolapse

0.86

0.12

1.5

3.2

—

Delivery

1.12

0.11

2.8

2.9

—

HSIL lesion of the cervix uteri

1.14

0.10

1.6

3.1

—

Faecal incontinence

1.11

0.09

1.4

2.4

—

Alzheimer disease, excluding more controls

0.88

0.09

4.5

3.1

—

Premature rupture of membranes

1.05

0.08

4.7

3.0

—

Irregular menses

122

0.91

0.08

3.8

2.8

—

Hypertrophy of breast

0.82

0.08

4.2

2.8

—

Postpartum haemorrhage

1.09

0.08

3.9

3.1

—

Radiculopathy

1.14

0.08

2.4

3.7

—

Unspecified lump in breast

0.86

0.07

1.3

2.7

—

False labour

0.87

0.07

4.9

3.6

—

Endometriosis

0.90

0.07

2.1

3.2

—

Polyp of the female genital tract

1.10

0.07

2.5

3.2

—

Female infertility

0.88

0.07

1.9

3.6

—

Early onset COPD, excluding more controls

1.02

0.07

1.4

2.6

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.92

0.05

4.9

3.0

—

Other maternal disorders predominantly related to pregnancy

131

1.05

0.04

2.3

3.2

—

Cervical disc disorders

219

0.96

0.03

2.3

3.4

—

Other degenerative diseases of the nervous system

121

1.05

0.02

6.6

3.3

—

Other noninflammatory disorders of uterus, except cervix

1.07

0.02

2.1

3.2

—

Other diseases of upper respiratory tract

378

1.01

0.00

3.4

3.1

—

37.40

—

Injury of muscle and tendon at forearm level

0.00

0.0

2.4

—

Tibial collateral bursitis [Pellegrini-Stieda]

0.00

0.0

2.3

—

Alzheimer’s disease (undefined), excluding more controls

0.00

0.0

1.6

—

Other abnormal auditory perceptions

0.00

0.0

3.4

—

Abnormal findings on diagnostic imaging of breast

0.00

0.0

2.3

—

Emotional disorders starting during childhood or adolescence

0.00

0.0

3.2

—

Anxious personality disorder

0.00

0.0

3.4

—

Spinal osteochondrosis

0.00

0.0

3.2

—

Hypertrophy of (infrapatellar) fat pad

0.00

0.0

3.2

—

Frostbite

0.00

0.0

2.2

—

Optic atrophy

0.00

0.0

2.2

—

Exposure to excessive natural cold

0.00

0.0

4.7

—

Mature T/NK-cell lymphomas, hilmo

0.00

0.0

2.0

—

Benign neoplasm: Lip

0.00

0.0

1.9

—

Childhood allergy (age < 16)

0.00

0.0

2.2

—

Beningn neoplasm: Meninges, unspecified

0.00

0.0

2.1

—

Other protozoal intestinal diseases

0.00

0.0

3.0

—

Other disorders of central nervous system

0.00

0.0

2.4

—

Cauda equina syndrome

0.00

0.0

2.2

—

Optic atrophy

0.00

0.0

2.2

—

Tarsal tunnel syndrome

0.00

0.0

2.6

—

Malignant cancer of tonsil and base of tongue

0.00

0.0

1.7

—

Other protozoal intestinal diseases

0.00

0.0

4.1

—

Traumatic ischaemia of muscle

0.00

0.0

5.4

—

Other and unspecified bullous disorders

0.00

0.0

2.2

—

Corneal degeneration

0.00

0.0

2.3

—

Endometriosis of intestine

0.00

0.0

3.8

—

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

0.00

0.0

1.2

—

Communicating hydrocephalus

0.00

0.0

2.6

—

Thyroiditis, unspecified

0.00

0.0

4.2

—

Other abortion

0.00

0.0

3.2

—

Primary adrenocortical insufficiency

0.00

0.0

2.2

—

Other acute disseminated demyelination

0.00

-0.00

0.0

4.6

—

Fasciculation

0.00

-0.00

0.0

2.4

—

Benign neoplasm: Other/unspecified site

0.00

-0.00

0.0

2.2

—

Malignant neoplasm of larynx

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Oesophagus

0.00

-0.00

0.0

2.4

—

Iridocyclitis in diseases classified elsewhere

0.00

-0.00

0.0

2.2

—

Other congenital malformations of face and neck

0.00

-0.00

0.0

4.1

—

Lagophthalmos

0.00

-0.00

0.0

2.4

—

Occlusion and stenosis of arteries, not leading to stroke

0.00

-0.00

0.0

2.4

—

Benign neoplasm: Spinal meninges

0.00

-0.00

0.0

2.2

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

0.00

-0.00

0.0

3.4

—

Specific development disorders of speech and language

0.00

-0.00

0.0

2.4

—

Anoxic brain damage

0.00

-0.00

0.0

2.9

—

Inflammation of lacrimal passages (chronic)

0.00

-0.00

0.0

2.6

—

Suppurative otitis media, unspecified

0.00

-0.00

0.0

2.0

—

Adhesive middle ear disease

0.00

-0.00

0.0

2.2

—

Benign neoplasm: Brain, supratentorial

0.00

-0.00

0.0

2.7

—

Respiratory conditions due to other external agents

0.00

-0.00

0.0

2.0

—

Obsessive-compulsive disorder

0.00

-0.00

0.0

4.1

—

Arthropathy in ulcerative colitis

0.00

-0.00

0.0

2.8

—

Malignant neoplasm, without specification of site

0.00

-0.00

0.0

1.1

—

Impacted maxillary molar

0.00

-0.00

0.0

2.8

—

Major anomalies of jaw size

0.00

-0.00

0.0

4.8

—

Serous carcinoma of ovary, including Hilmo

0.00

-0.00

0.0

1.4

—

Blood alcohol or alcohol intoxication level

0.00

-0.00

0.0

2.2

—

Dependent personality disorder

0.00

-0.00

0.0

3.0

—

Malignant neoplasm of tongue

0.00

-0.00

0.0

1.2

—

Polycythaemia vera

0.00

-0.00

0.0

1.2

—

Other degenerative diseases of the basal ganglia

0.00

-0.00

0.0

2.0

—

Intussusception

0.00

-0.00

0.0

2.1

—

Benign neoplasm: Appendix

0.00

-0.00

0.0

2.2

—

Malignant neoplasm of tonsil

0.00

-0.00

0.0

1.2

—

Hypersensitivity pneumonitis due to organic dust

0.00

-0.00

0.0

2.0

—

Other congenital malformations of peripheral vascular system

0.00

-0.00

0.0

3.2

—

Late syphilis

0.00

-0.00

0.0

2.0

—

Malignant neoplasm of ovary

0.00

-0.00

0.0

1.3

—

Congenital malformations of the respiratory system

0.00

-0.00

0.0

2.2

—

Malignant neoplasm of oropharynx

0.00

-0.00

0.0

1.2

—

Varus deformity, not elsewhere classified

0.00

-0.00

0.0

3.3

—

Dyshidrosis [pompholyx]

0.00

-0.00

0.0

2.7

—

Sequelae of other accidents

0.00

-0.00

0.0

1.2

—

Pain and other conditions associated with female genital organs and menstrual cycle

0.96

-0.00

1.6

3.1

—

Other disorders of choroid

0.00

-0.00

0.0

2.2

—

Other sexually transmitted chlamydial diseases

0.00

-0.00

0.0

2.0

—

Male infertility

0.00

-0.00

0.0

7.4

—

Benign neoplasm: Connective and other soft tissue, unspecified

0.00

-0.00

0.0

1.2

—

Shoulder region

0.00

-0.00

0.0

2.0

—

Postpartum hemorraghe, parous women as controls

1.01

-0.00

3.9

3.4

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

0.00

-0.00

0.0

1.2

—

Routine general health check-up of defined subpopulation

0.00

-0.00

0.0

2.3

—

Hypertrichosis

0.00

-0.00

0.0

3.4

—

0.00

-0.00

0.0

3.2

—

Alcohol abuse counselling and surveillance

0.00

-0.00

0.0

5.7

—

Small cell lung cancer, including Hilmo

0.00

-0.00

0.0

1.1

—

Vitiligo

0.00

-0.00

0.0

3.4

—

Campylobacter enteritis

0.00

-0.00

0.0

4.2

—

Other bursitis of knee

0.00

-0.00

0.0

5.8

—

Pedestrian injured in other and unspecified transport accidents

0.00

-0.00

0.0

2.2

—

Contact with lifting and transmission devices, not elsewhere classified

0.00

-0.00

0.0

5.0

—

Exposure to smoke, fire and flames

0.00

-0.00

0.0

3.6

—

Malignant neoplasm of tonsil, including Hilmo

0.00

-0.00

0.0

1.2

—

Other nonscarring hair loss

0.00

-0.00

0.0

3.0

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

0.00

-0.00

0.0

2.6

—

Other and unspecified injuries of thorax

0.00

-0.00

0.0

2.2

—

Type 1 diabetes, wide definition, subgroup 2

0.00

-0.00

0.0

2.4

—

Poisoning by medicine, drug-induced

0.00

-0.00

0.0

3.4

—

Idiopathic urticaria

0.00

-0.00

0.0

2.7

—

Malignant neoplasm of oral cavity

0.00

-0.00

0.0

1.1

—

Open wound of shoulder and upper arm

0.00

-0.00

0.0

3.8

—

Other and unspecified injuries of abdomen, lower back and pelvis

0.00

-0.00

0.0

2.2

—

Adult respiratory distress syndrome

0.00

-0.00

0.0

1.2

—

Endometriosis of ovary

0.99

-0.00

2.8

3.2

—

Crushing injury of wrist and hand

0.00

-0.00

0.0

4.1

—

Burns and corrosions of multiple and unspecified body regions

0.00

-0.00

0.0

1.9

—

Operations for atrial fibrillation

0.00

-0.00

0.0

3.9

—

Malignant neoplasm of oropharynx, including Hilmo

0.00

-0.00

0.0

1.2

—

Bruxism

0.00

-0.00

0.0

3.7

—

Foreign body in ear

0.00

-0.00

0.0

2.7

—

Complications following infusion, transfusion and therapeutic injection

0.00

-0.00

0.0

2.7

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

0.00

-0.00

0.0

4.3

—

Toxic effect of alcohol

0.00

-0.00

0.0

3.8

—

Other superficial mycoses

0.00

-0.00

0.0

4.0

—

Respiratory tuberculosis, clinically confirmed

0.00

-0.00

0.0

2.0

—

Other lack of coordination

0.00

-0.00

0.0

2.2

—

Malignant neoplasm of liver and intrahepatic bile ducts

0.00

-0.00

0.0

1.1

—

Infection of intervertebral disc (pyogenic)

0.00

-0.00

0.0

2.4

—

Epiphora

0.00

-0.00

0.0

3.3

—

Benign neoplasm: Spinal cord

0.00

-0.00

0.0

2.4

—

Hepatocellular carcinoma

0.00

-0.00

0.0

1.2

—

Burn and corrosion of hip and lower limb, except ankle and foot

0.00

-0.00

0.0

2.5

—

Burn and corrosion of head and neck

0.00

-0.00

0.0

3.9

—

Other specified/unspecified necrotizing vasculopathies

0.00

-0.00

0.0

2.0

—

Causalgia

0.00

-0.00

0.0

2.9

—

Hypothermia

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Vagina

0.00

-0.00

0.0

2.7

—

Congenital malformations of the respiratory system

0.00

-0.00

0.0

2.0

—

Use of cabergoline

0.00

-0.00

0.0

2.8

—

Use of amantadine

0.00

-0.00

0.0

2.0

—

Use of rotigotine

0.00

-0.00

0.0

2.0

—

Malignant neoplasm of brain

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of larynx, including Hilmo

0.00

-0.00

0.0

1.2

—

Other predominantly sexually transmitted diseases, not elsewhere classified

0.94

-0.00

3.4

3.0

—

Cellulitis of external ear

0.00

-0.00

0.0

2.2

—

Hereditary ataxia

0.00

-0.00

0.0

2.0

—

Use of glatiramer acetate

0.00

-0.00

0.0

3.4

—

Laparoscopic left hemicolectomy

0.00

-0.00

0.0

2.0

—

Other disorders of cornea

0.98

-0.00

8.0

2.9

—

Other overlap syndromes

0.00

-0.00

0.0

3.4

—

Premature separation of placenta [abruptio placentae]

0.00

-0.00

0.0

3.2

—

Other specified and unspecified strabismus

0.00

-0.00

0.0

2.2

—

Venous complications and haemorrhoids in pregnancy

0.00

-0.00

0.0

3.4

—

Palindromic rheumatism

0.00

-0.00

0.0

2.9

—

Failed induction of labour

0.00

-0.00

0.0

3.2

—

HSIL lesion of the vagina

0.00

-0.00

0.0

4.8

—

Endometriosis of fallopian tube

0.00

-0.00

0.0

4.0

—

Torticollis

0.00

-0.00

0.0

2.3

—

Sexual dysfunction

0.00

-0.00

0.0

3.8

—

Diastasis of muscle

0.00

-0.00

0.0

3.4

—

Acute otitis externa, noninfective

0.00

-0.00

0.0

2.2

—

Malnutrition

0.00

-0.00

0.0

2.0

—

Benign mammary dysplasia

0.92

-0.00

1.8

2.6

—

Cerebral atherosclerosis

0.00

-0.00

0.0

2.2

—

Iliotibial band syndrome

0.00

-0.00

0.0

2.2

—

Disorders of iron metabolism

0.00

-0.00

0.0

5.7

—

Severe visual impairment, monocular

0.00

-0.00

0.0

2.2

—

Patellar tendinitis

0.00

-0.00

0.0

4.7

—

Haemorrhagic disorder due to circulating anticoagulants

0.00

-0.00

0.0

2.0

—

Use of interferon beta-1a

0.00

-0.00

0.0

4.0

—

Retinoschisis and retinal cysts

0.00

-0.00

0.0

2.4

—

Circumscribed brain atrophy

0.00

-0.00

0.0

2.6

—

Other disorders of thyroid

0.00

-0.00

0.0

2.4

—

Chronic hepatitis NAS

0.00

-0.00

0.0

2.4

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

-0.00

0.0

2.4

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

0.00

-0.00

0.0

2.0

—

Other and unspecified haemorrhagic conditions

0.00

-0.00

0.0

1.2

—

Von Willebrand disease

0.00

-0.00

0.0

3.0

—

Other and unspecified aplastic anaemias

0.00

-0.00

0.0

2.4

—

Disorders of speech understanding and production

0.00

-0.00

0.0

2.0

—

Papilloedema, unspecified

0.00

-0.00

0.0

3.0

—

Other forms of systemic lupus erythematosus

0.00

-0.00

0.0

2.4

—

Premenstrual syndrome

0.00

-0.00

0.0

3.8

—

Respiratory tuberculosis, confirmed

0.00

-0.00

0.0

2.7

—

Nystagmus and other irregular eye movements

0.00

-0.00

0.0

2.4

—

Congenital malformations of uterus and cervix

0.00

-0.00

0.0

4.2

—

Other eating disorders

0.00

-0.00

0.0

3.0

—

Horner syndrome

0.00

-0.00

0.0

2.4

—

Obstructive hydrocephalus

0.00

-0.00

0.0

2.2

—

Toxic effect of carbon monoxide

0.00

-0.00

0.0

2.2

—

Small cell lung cancer

0.00

-0.00

0.0

1.1

—

Hepatocellular carcinoma, including Hilmo

0.00

-0.00

0.0

1.2

—

Disorder of thyroid, unspecified

0.00

-0.00

0.0

2.2

—

Acute drug-induced interstitial lung disorder

0.00

-0.00

0.0

2.4

—

Non-invasive ventilation

0.90

-0.00

3.8

3.9

—

Late syphilis

0.00

-0.00

0.0

2.4

—

Atlantoaxial subluxation

0.00

-0.00

0.0

2.4

—

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

0.00

-0.00

0.0

4.2

—

Pyogenic granuloma

0.00

-0.00

0.0

3.7

—

Female infertility, cervical, vaginal, other or unspecified origin

0.96

-0.00

2.3

3.6

—

Carcinoma in situ of breast, other/unspecified

0.00

-0.00

0.0

2.0

—

Other corneal oedema

0.00

-0.00

0.0

2.4

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Kappa light chains [Mass/time] in 24 hour Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS